Topical Use of 20% Beta Caryophyllene Alone And In Combination With 0.025% Capsaicin for Pain Caused by Osteoarthritis Of The Knee
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03152578 |
|
Recruitment Status :
Completed
First Posted : May 15, 2017
Last Update Posted : January 6, 2020
|
Sponsor:
Panag Pharma Inc.
Information provided by (Responsible Party):
Panag Pharma Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | June 30, 2019 |
| Actual Study Completion Date : | July 31, 2019 |